Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
24
NCT04697758
Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema
Phase: Phase 1/2
Role: Lead Sponsor
Start: Dec 10, 2020
Completion: Oct 1, 2022
NCT04746963
Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration
Start: Feb 1, 2021
NCT05859776
Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)
Start: Dec 19, 2023
Completion: May 31, 2025